Glaxosmithkline Pharmaceuticals Share Price
Know More₹2,651.90-30.45 (-1.14%)
04:01 PM, 13-Mar-2025₹2,657.80-25.30 (-0.94%)
03:46 PM, 13-Mar-2025BSE : 500660
NSE : GLAXO
Sector : Health care
ISIN Code : INE159A01016
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 13-Mar-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 44,926 |
Traded Value (₹ Cr) | 0.45 |
Volume (Shares) | 1,691 |
Face Value (₹) | 10 |
52-Week High (₹) | 3,087.95 |
52-Week High Date | 22-Aug-2024 |
52-Week Low (₹) | 1,825.05 |
52-Week Low Date | 15-Apr-2024 |
All Time High (₹) | 3,087.95 |
All Time High Date | 22-Aug-2024 |
All Time Low (₹) | 12.88 |
All Time Low Date | 19-Aug-1988 |
Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd News
Glaxosmi. Pharma Announcement
Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 45,026 |
| EPS - TTM (₹) [C] | 50.42 |
| P/E Ratio (X) [C] | 52.71 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 120.00 |
| Latest Dividend Date | 07-Nov-2024 |
| Dividend Yield (%) | 1.20 |
| Book Value Share (₹) [C] | 98.74 |
| P/B Ratio (₹) [C] | 26.92 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| SBI Magnum Midcap Fund (G) | 419.89 | 16,96,276 | 2.17 |
| SBI Magnum Midcap Fund (IDCW) | 419.89 | 16,96,276 | 2.17 |
| SBI Magnum Midcap Fund - Direct (G) | 419.89 | 16,96,276 | 2.17 |
| SBI Magnum Midcap Fund - Direct (IDCW) | 419.89 | 16,96,276 | 2.17 |
| Kotak Equity Opportunities (G) | 272.29 | 11,00,000 | 1.19 |
| Kotak Equity Opportunities - Direct (G) | 272.29 | 11,00,000 | 1.19 |
| Nippon India Pharma Fund (G) | 250.49 | 10,11,921 | 3.28 |
| Nippon India Pharma Fund (Bonus) | 250.49 | 10,11,921 | 3.28 |
| Nippon India Pharma Fund (IDCW) | 250.49 | 10,11,921 | 3.28 |
| Nippon India Pharma Fund - Direct (G) | 250.49 | 10,11,921 | 3.28 |
Load more
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 2,640.05 2,695.10 |
| Week Low/High (₹) | 2,605.45 2,798.00 |
| Month Low/High (₹) | 1,968.00 2,798.00 |
| Year Low/High (₹) | 1,842.05 3,088.00 |
| All time Low/High (₹) | 12.88 3,088.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -1.22% | -1.20% | -0.69% | -0.65% |
| 1 Month | 33.18% | 32.97% | -3.03% | -2.75% |
| 3 Month | 17.89% | 17.91% | -10.11% | -9.57% |
| 6 Month | -8.45% | -8.51% | -10.93% | -11.67% |
| 1 Year | 38.27% | 37.97% | 1.47% | 1.82% |
| 3 Year | 71.86% | 72.10% | 32.90% | 34.68% |
Company Info
Company Information
Independent Director : D Sundaram
Company Sec. & Compli. Officer : A A Nadkarni
Independent Director : P V Bhide
Independent Director : A N Roy
Non Executive Director : Subesh Williams
Chairperson : Renu S Karnad
Independent Director : Sunita Maheshwari
Independent Director : Manu Anand
Managing Director : Bhushan Akshikar
Whole Time Director & CFO : J. Chandy
Registered Office: GSK House, Dr Annie Besant Road Worli,Mumbai,Maharashtra-400030 Ph: 91-022-24959595
FAQs about Glaxosmithkline Pharmaceuticals Ltd
1. What's the Glaxosmithkline Pharmaceuticals Ltd share price today?
Glaxosmithkline Pharmaceuticals Ltd share price was Rs 2,651.90 at 04:01 PM IST on 13th Mar 2025. Glaxosmithkline Pharmaceuticals Ltd share price was down by 1.14% from the previous closing price of Rs 2,682.35. Glaxosmithkline Pharmaceuticals Ltd share price trend:
- Last 1 Month: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 33.18% on BSE.
- Last 3 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 17.89% on BSE.
- Last 12 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 38.27% on BSE.
- Last 3 Years: Glaxosmithkline Pharmaceuticals Ltd share price moved up by 71.86% on BSE.
2. How can I quickly analyse the performance of the Glaxosmithkline Pharmaceuticals Ltd stock?
The performance of the Glaxosmithkline Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 52.71
- Price to book value ratio is 26.92
- Dividend yield of 1.20
- The EPS (trailing 12 months) of the Glaxosmithkline Pharmaceuticals Ltd stock is Rs 50.42
3. What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?
Glaxosmithkline Pharmaceuticals Ltd has a market capitalisation of Rs 44,926 crore.
4. What is Glaxosmithkline Pharmaceuticals Ltd's 52-week high/low share price?
The Glaxosmithkline Pharmaceuticals Ltd’s 52-week high share price is Rs 3,087.95 and 52-week low share price is Rs 1,825.05.
5. Is the Glaxosmithkline Pharmaceuticals Ltd profitable?
On a consolidated basis, Glaxosmithkline Pharmaceuticals Ltd reported a profit of Rs 228.58 crore on a total income of Rs 981.42 crore for the quarter ended 2024. For the year ended Dec 2024, Glaxosmithkline Pharmaceuticals Ltd had posted a profit of Rs 229.88 crore on a total income of Rs 984.49 crore.
6. Which are Glaxosmithkline Pharmaceuticals Ltd’s peers in the Health care sector?
Glaxosmithkline Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Aurobindo Pharma, Abbott India, Alkem Lab, Glaxosmi. Pharma, Glenmark Pharma., Biocon, Ipca Labs..
7. Who owns how much in Glaxosmithkline Pharmaceuticals Ltd?
Key changes to the Glaxosmithkline Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 75.00 per cent as of Dec 2024 from 75.00 per cent as of Mar 2024.
